Copyright
©The Author(s) 2016.
World J Diabetes. Oct 15, 2016; 7(18): 441-448
Published online Oct 15, 2016. doi: 10.4239/wjd.v7.i18.441
Published online Oct 15, 2016. doi: 10.4239/wjd.v7.i18.441
Table 1 Body weight parameters: Baseline[24]
| BMI (kg/m2) | Body weight (kg) | WC (cm) | |
| Metformin | 36.6 ± 3.5 | 103.2 ± 6.3 | 122.3 ± 7.0 |
| Liraglutide | 39.3 ± 4.2 | 108.9 ± 15.1 | 124.9 ± 9.9 |
| COMBI | 37.6 ± 5.1 | 105.5 ± 20.6 | 121.9 ± 17.7 |
- Citation: Chatterjee S, Ghosal S, Chatterjee S. Glucagon-like peptide-1 receptor agonists favorably address all components of metabolic syndrome. World J Diabetes 2016; 7(18): 441-448
- URL: https://www.wjgnet.com/1948-9358/full/v7/i18/441.htm
- DOI: https://dx.doi.org/10.4239/wjd.v7.i18.441